Lyell Immunopharma Statistics

Total Valuation

LYEL has a market cap or net worth of $386.56 million. The enterprise value is -$31.53 million.

Market Cap	386.56M
Enterprise Value	-31.53M

Important Dates

The next estimated earnings date is Tuesday, November 5, 2024, after market close.

Earnings Date	Nov 5, 2024
Ex-Dividend Date	n/a

Share Statistics

LYEL has 256.00 million shares outstanding. The number of shares has increased by 1.62% in one year.

Shares Outstanding	256.00M
Shares Change (YoY)	+1.62%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	3.50%
Owned by Institutions (%)	52.58%
Float	165.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.70
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 16.19, with a Debt / Equity ratio of 0.11.

Current Ratio	16.19
Quick Ratio	15.90
Debt / Equity	0.11
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -32.26% and return on invested capital (ROIC) is -19.63%.

Return on Equity (ROE)	-32.26%
Return on Assets (ROA)	-18.84%
Return on Capital (ROIC)	-19.63%
Revenue Per Employee	$241
Profits Per Employee	-$938,656
Employee Count	224
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.64% in the last 52 weeks. The beta is -0.54, so LYEL's price volatility has been lower than the market average.

Beta (5Y)	-0.54
52-Week Price Change	-0.64%
50-Day Moving Average	1.46
200-Day Moving Average	2.01
Relative Strength Index (RSI)	60.24
Average Volume (20 Days)	633,653

Short Selling Information

The latest short interest is 13.76 million, so 5.38% of the outstanding shares have been sold short.

Short Interest	13.76M
Short Previous Month	15.03M
Short % of Shares Out	5.38%
Short % of Float	8.33%
Short Ratio (days to cover)	21.51

Income Statement

In the last 12 months, LYEL had revenue of $54,000 and -$210.26 million in losses. Loss per share was -$0.83.

Revenue	54,000
Gross Profit	54,000
Operating Income	-224.56M
Pretax Income	-210.26M
Net Income	-210.26M
EBITDA	-204.47M
EBIT	-224.56M
Loss Per Share	-$0.83

Full Income Statement

Balance Sheet

The company has $491.12 million in cash and $60.22 million in debt, giving a net cash position of $430.90 million or $1.68 per share.

Cash & Cash Equivalents	491.12M
Total Debt	60.22M
Net Cash	430.90M
Net Cash Per Share	$1.68
Equity (Book Value)	566.50M
Book Value Per Share	2.21
Working Capital	468.95M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$158.43 million and capital expenditures -$581,000, giving a free cash flow of -$159.01 million.

Operating Cash Flow	-158.43M
Capital Expenditures	-581,000
Free Cash Flow	-159.01M
FCF Per Share	-$0.62

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-415,844.44%
Pretax Margin	-389,368.52%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-294,466.67%

Dividends & Yields

LYEL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.62%
Shareholder Yield	-1.62%
Earnings Yield	-52.65%
FCF Yield	-39.82%

Analyst Forecast

The average price target for LYEL is $3.50, which is 131.79% higher than the current price. The consensus rating is "Buy".

Price Target	$3.50
Price Target Difference	131.79%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LYEL has an Altman Z-Score of 1.11 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.11
Piotroski F-Score	1